Marked increase in serum IgM during treatment of Waldenstöm's macroglobulinemia with cladribine [9]

New England Journal of Medicine

Volumn 348, Issue 20, 2003, Pages 2045-2046

  Krishna, Vandana M ^a   Carey, Robert W ^a   Bloch, Kurt J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLADRIBINE; IMMUNOGLOBULIN M;

ADULT; AGED; B CELL LYMPHOMA; BLOOD VISCOSITY; CASE REPORT; DRUG EFFICACY; DYSPNEA; FATIGUE; FEMALE; HUMAN; IMMUNOGLOBULIN PRODUCTION; LETTER; MALE; PHYSICAL EXAMINATION; PLASMAPHERESIS; PRIORITY JOURNAL; TUMOR BIOPSY; TUMOR CELL DESTRUCTION; WALDENSTROEM MACROGLOBULINEMIA;

AGED; ANTINEOPLASTIC AGENTS; CLADRIBINE; FEMALE; HUMANS; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; WALDENSTROM MACROGLOBULINEMIA;

EID: 0038414541     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200305153482025     Document Type: Letter

References (4)

1. Dimopoulos MA, Panayiotidis P, Moulopoulos LA, Sfikakis P, Dalakas M. Waldenström's macroglobulinemia: clinical features, complications, and management. J Clin Oncol 2000;18:214-26.
2. Hellmann A, Lewandowsid K, Zaucha JM, Bieniaszewska M, Halaburda K, Robak T. Effect of a 2-hour infusion of 2-chlorodeoxyadenosine in the treatment of refractory or previously untreated Waldenström's macroglobulinemia. Eur J Haematol 1999;63:35-41.
3. Bloch KJ, Mald DG. Hyperviscosity syndromes associated with immunoglobulin abnormalities. Semin Hematol 1973;10:113-24.
4. Dann EJ, Gillis S, Polliack A, Okon E, Rund D, Rachmilewitz EA. Tumor lysis syndrome following treatment with 2-chlorodeoxyadenosine for refractory chronic lymphocytic leukemia. N Engl J Med 1993;329:1547-8.